Company intelligence / Profile preview
Crioestaminal
- Ownership
- Private
- Development stage
- Commercial
Overview
Crioestaminal is a leading European private cord blood bank specializing in the collection, processing, cryopreservation, and research of umbilical cord blood/tissue-derived stem cells. It has released samples for both allogeneic transplant (e.g., SCID) and autologous experimental therapies (e.g., cerebral palsy). The company holds patents related to wound healing and cardiac tissue repair using stem cells. It is accredited by AABB and ISO 9001 standards.
- Therapeutic areas
- OncologyEndocrinologyImmunologyCardiovascularNeurology
- Modalities
- Stem cell therapyCell therapy (specifically umbilical cord blood and tissue-derived stem cells)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Crioestaminal.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crioestaminal.